Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Edwards Lifesciences Earnings Preview: What to Expect

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a global medical technology company specializing in structural heart disease treatments, with a market capitalization of approximately $49.1 billion. The company develops innovative products, including heart valves and related technologies, partnering with physicians to improve cardiovascular health, extend patients’ lives, and enhance their overall quality of life.

EW is set to report its Q3 2026 earnings after the market closes on Wednesday, November 4, 2026. Ahead of the release, analysts expect diluted EPS of 73 cents, up 9% from 67 cents in the year-ago quarter. Likewise, EW has exceeded Wall Street’s EPS estimates in three of the past four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.